Spectrum Pharmaceuticals, Inc.
SPPINASDAQHealthcare
$1.03
$-0.01(-0.49%)
Market Cap$210377146
P/E Ratio—
52W High$1.57
52W Low$0.32
Spectrum Pharmaceuticals, Inc. (SPPI) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · SPPI · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2022-12 | 2021-12 | 2020-12 | 2019-12 | 2018-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $10.11M | $0.00M | $0.00M | $22.61M | $109.33M |
| Cost of Revenue | $1.79M | $0.00M | $0.00M | $12.01M | $26.76M |
| Gross Profit | $8.32M | $0.00M | $0.00M | $10.61M | $82.58M |
| Gross Margin %(computed) | 82.28% | — | — | 46.91% | 75.53% |
| Operating Expenses | |||||
| R&D Expenses | $42.20M | $87.30M | $109.38M | $79.33M | $94.96M |
| G&A Expenses | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Operating Expenses | $81.02M | $147.70M | $169.73M | $140.70M | $213.75M |
| Operating Income | ($72.70M) | ($147.70M) | ($169.73M) | ($144.03M) | ($131.18M) |
| Operating Margin %(computed) | -718.78% | — | — | -636.89% | -119.98% |
| Interest Income | $0.97M | $0.16M | $1.34M | $5.00M | $0.00M |
| Interest Expense | $1.00M | $0.00M | $0.00M | ($5.00M) | $0.34M |
| Income Before Tax | ($78.06M) | ($158.43M) | ($171.33M) | ($144.59M) | ($120.01M) |
| Income Tax Expense | $0.05M | $0.00M | ($0.06M) | ($9.21M) | $0.00M |
| Net Income | ($78.10M) | ($158.44M) | ($171.27M) | ($135.39M) | ($120.01M) |
| Net Margin %(computed) | -772.24% | — | — | -598.66% | -109.77% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.43 | $-1.02 | $-1.38 | $-1.22 | $-1.16 |
| Wtd Avg Shares | 183.24M | 154.86M | 124.39M | 110.59M | 103.31M |
| EBITDA | ($77.06M) | ($147.42M) | ($169.47M) | ($154.59M) | ($93.50M) |
| EBITDA Margin %(computed) | -761.91% | — | — | -683.56% | -85.52% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more Spectrum Pharmaceuticals, Inc. data
About Spectrum Pharmaceuticals, Inc. (SPPI) Income Statement
Spectrum Pharmaceuticals, Inc. (SPPI) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2022, SPPI reported revenue of $0.01B, gross profit of $0.01B (gross margin 82.28%), and net income of ($0.08B) — a net profit margin of -772.24%.
Frequently asked questions
SPPI · 4 questionsSpectrum Pharmaceuticals, Inc. (SPPI) reported revenue of $0.01B for 2022, up —% year-over-year.
SPPI revenueSPPI salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09